Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 27;16(1):81.
doi: 10.1186/s12967-018-1449-z.

Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy

Affiliations

Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy

Ming Chen et al. J Transl Med. .

Abstract

Background: Primary pulmonary enteric adenocarcinoma (PEAC) is an extremely rare variant of invasive lung cancer. It is highly heterogeneous while shares some common morphologic and immunohistochemical features with usual pulmonary adenocarcinoma (PAC) and colorectal adenocarcinoma (CRAC), making the differential diagnosis difficult. At present there are only limited studies about distinctive features of primary PEAC and the results are often inconsistent.

Methods: We retrospectively analyzed total 129 primary PEACs and 50 CRACs that were published since 1991 or diagnosed in our centre. Among them eight typical samples of primary PEACs and usual PACs were detected by targeted exome sequencing.

Results: The combination of CK7+/CDX2+ acquires high sensitivity (71.3%) and specificity (82%) in differential diagnosis of PEACs from CRAC. The primary PEACs harbor a high incidence of KRAS mutation but almost absent of EGFR mutation. Moreover, compared with usual PACs, the primary PEACs have higher nonsynonymous tumor mutation burden and more frequent MMR mutation.

Conclusions: The combination of CK7+/CDX2+ immunostaining and the distinctive genetic signatures, including low incidence of sensitivity genes mutations and high tumor mutation burden, is an important supplementary to the clinical differential diagnosis of primary PEACs. Our findings thus have significant implications for development of individualized treatment strategy in these patients.

Keywords: Immunohistochemistry; Immunotherapy; Primary pulmonary enteric adenocarcinoma; Targeted therapy; Tumor mutation burden.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The representative images of the histopathology for usual PAC (a), primary PEAC (b) and CRAC (c) were shown. Primary PEACs consisted predominantly of enteric-type components that tall columnar cells arranged in irregular glandular cavities with central necrosis. Left, H&E, ×50; Right, H&E, ×200. H&E hematoxylin and eosin staining, PAC pulmonary adenocarcinoma, PEAC pulmonary enteric adenocarcinoma, CRAC colorectal adenocarcinoma. Rightwards arrow indicates the nipples of pulmonary adenocarcinoma; rightwards double arrow indicates the tumor cells were tall columnar cells with eosinophilic cytoplasm; black diamond suit indicates central necrosis; heavy concave pointed black rightwards arrow indicates the normal intestinal epithelium; asterisk indicates mitoses
Fig. 2
Fig. 2
The representative images of the IHC markers immunostaining for usual PAC, primary PEAC and CRAC were shown. H&E, ×100. H&E hematoxylin and eosin staining, PAC pulmonary adenocarcinoma, PEAC pulmonary enteric adenocarcinoma, CRAC colorectal adenocarcinoma, CK cytokeratin, TTF‑1 thyroid transcription factor 1, CDX2 caudal type homeobox 2
Fig. 3
Fig. 3
Primary PEACs harbored a high incidence of MMR genes mutation and higher TMB compared with usual PACs. a 4/5 primary PEAC patients harbored MMR genes mutation and the mutation frequency of core MMR genes (MLH1, PMS2, MSH2 and MSH6) and the TMB (muts/Mb) of each patient was showed. b The TMB of primary PEACs (mean: 80.0 ± 20.1 muts/Mb, N = 5) was significantly higher than that of usual PACs (mean: 9.5 ± 2.9 muts/Mb, N = 3) (t = − 2.627, P (2-tailed) = 0.039, P < 0.05)

References

    1. Tsao MS, Fraser RS. Primary pulmonary adenocarcinoma with enteric differentiation. Cancer. 1991;68:1754–1757. doi: 10.1002/1097-0142(19911015)68:8<1754::AID-CNCR2820680818>3.0.CO;2-E. - DOI - PubMed
    1. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G, Garg K, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011;8:381–385. doi: 10.1513/pats.201107-042ST. - DOI - PubMed
    1. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10:1240–1242. doi: 10.1097/JTO.0000000000000663. - DOI - PubMed
    1. Nottegar A, Tabbo F, Luchini C, Brunelli M, Bria E, Veronese N, Santo A, Cingarlini S, Gilioli E, Ogliosi C, et al. Pulmonary adenocarcinoma with enteric differentiation: immunohistochemistry and molecular morphology. Appl Immunohistochem Mol Morphol. 2016 - PubMed
    1. Nottegar A, Tabbo F, Luchini C, Guerrera F, Gaudiano M, Bria E, Brunelli M, Chilosi M, Inghirami G. Pulmonary adenocarcinoma with enteric differentiation: dissecting oncogenic genes alterations with DNA sequencing and FISH analysis. Exp Mol Pathol. 2017;102:276–279. doi: 10.1016/j.yexmp.2017.02.014. - DOI - PubMed

Substances